中文 English
Other
Published in : Mar 05, 2025
Global Oncology Imaging Equipment Market Research Report - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2033)

Version Type

Contact us for more information
Email: market@lookwhole.com
  • 5400USD
  • 4200USD
  • 3880USD
  • 5400USD

Report Summary Catalogue Methodological


Definition and Scope:
Oncology imaging equipment refers to specialized medical devices used for the diagnosis, monitoring, and treatment of cancer. These equipment include various imaging modalities such as X-ray, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and ultrasound. Oncology imaging equipment plays a crucial role in the detection and staging of cancer, as well as in guiding treatment decisions and assessing treatment response. These technologies help healthcare professionals visualize tumors, monitor their growth or regression, and evaluate the effectiveness of cancer therapies.
The market for oncology imaging equipment is experiencing significant growth driven by several key factors. Firstly, the increasing incidence of cancer globally, coupled with the growing aging population, is driving the demand for advanced imaging technologies for early detection and accurate diagnosis of cancer. Secondly, technological advancements in imaging modalities, such as the development of hybrid imaging systems like PET-CT and PET-MRI, are enhancing the capabilities of oncology imaging equipment, leading to improved accuracy and efficiency in cancer diagnosis and treatment planning. Additionally, the rising investments in healthcare infrastructure, especially in emerging markets, are expanding access to oncology imaging equipment, further fueling market growth.
Moreover, the shift towards personalized medicine and precision oncology is also driving the demand for oncology imaging equipment. These technologies enable healthcare providers to tailor treatment plans based on individual patient characteristics and tumor biology, leading to more effective and targeted cancer therapies. Furthermore, the increasing focus on research and development activities in oncology imaging, including the integration of artificial intelligence and machine learning algorithms for image analysis, is expected to drive innovation and propel market growth. Overall, the market for oncology imaging equipment is poised for continued expansion as the demand for advanced imaging technologies in cancer care continues to rise globally.
The global Oncology Imaging Equipment market size was estimated at USD 841.88 million in 2024, exhibiting a CAGR of 12.40% during the forecast period.
This report offers a comprehensive analysis of the global Oncology Imaging Equipment market, examining all key dimensions. It provides both a macro-level overview and micro-level market details, including market size, trends, competitive landscape, niche segments, growth drivers, and key challenges.
Report Framework and Key Highlights: Market Dynamics: Identification of major market drivers, restraints, opportunities, and challenges.
Trend Analysis: Examination of ongoing and emerging trends impacting the market.
Competitive Landscape: Detailed profiles and market positioning of major players, including market share, operational status, product offerings, and strategic developments.
Strategic Analysis Tools: SWOT Analysis, Porter’s Five Forces Analysis, PEST Analysis, Value Chain Analysis
Market Segmentation: By type, application, region, and end-user industry.
Forecasting and Growth Projections: In-depth revenue forecasts and CAGR analysis through 2033.
This report equips readers with critical insights to navigate competitive dynamics and develop effective strategies. Whether assessing a new market entry or refining existing strategies, the report serves as a valuable tool for:
Industry players
Investors
Researchers
Consultants
Business strategists
And all stakeholders with an interest or investment in the Oncology Imaging Equipment market.
Global Oncology Imaging Equipment Market: Segmentation Analysis and Strategic Insights
This section of the report provides an in-depth segmentation analysis of the global Oncology Imaging Equipment market. The market is segmented based on region (country), manufacturer, product type, and application. Segmentation enables a more precise understanding of market dynamics and facilitates targeted strategies across product development, marketing, and sales.
By breaking the market into meaningful subsets, stakeholders can better tailor their offerings to the specific needs of each segment—enhancing competitiveness and improving return on investment.
Global Oncology Imaging Equipment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Companies Profiled
GE Healthcare
Siemens Healthineers
Philips Healthcare
Varian Medical Systems
Canon Medical Systems
Toshiba Medical Systems
NorthStar Medical Radioisotopes
Positron
Neusoft Medical Systems
Cubresa
United Imaging Healthcare
Market Segmentation by Type
X-Ray Imaging
MRI
Others
Market Segmentation by Application
Hospital
Clinic
Others
Geographic Segmentation North America: United States, Canada, Mexico
Europe: Germany, France, Italy, U.K., Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium, Russia.
Asia-Pacific: China, Japan, South Korea, India, Australia, Indonesia, Malaysia, Philippines, Singapore, Thailand
South America: Brazil, Argentina, Colombia.
Middle East and Africa (MEA): Saudi Arabia, United Arab Emirates, Egypt, Nigeria, South Africa, Rest of MEA
Report Framework and Chapter Summary Chapter 1: Report Scope and Market Definition
This chapter outlines the statistical boundaries and scope of the report. It defines the segmentation standards used throughout the study, including criteria for dividing the market by region, product type, application, and other relevant dimensions. It establishes the foundational definitions and classifications that guide the rest of the analysis.
Chapter 2: Executive Summary
This chapter presents a concise summary of the market’s current status and future outlook across different segments—by geography, product type, and application. It includes key metrics such as market size, growth trends, and development potential for each segment. The chapter offers a high-level overview of the Oncology Imaging Equipment Market, highlighting its evolution over the short, medium, and long term.
Chapter 3: Market Dynamics and Policy Environment
This chapter explores the latest developments in the market, identifying key growth drivers, restraints, challenges, and risks faced by industry participants. It also includes an analysis of the policy and regulatory landscape affecting the market, providing insight into how external factors may shape future performance.
Chapter 4: Competitive Landscape
This chapter provides a detailed assessment of the market's competitive environment. It covers market share, production capacity, output, pricing trends, and strategic developments such as mergers, acquisitions, and expansion plans of leading players. This analysis offers a comprehensive view of the positioning and performance of top competitors.
Chapters 5–10: Regional Market Analysis
These chapters offer in-depth, quantitative evaluations of market size and growth potential across major regions and countries. Each chapter assesses regional consumption patterns, market dynamics, development prospects, and available capacity. The analysis helps readers understand geographical differences and opportunities in global markets.
Chapter 11: Market Segmentation by Product Type
This chapter examines the market based on product type, analyzing the size, growth trends, and potential of each segment. It helps stakeholders identify underexplored or high-potential product categories—often referred to as “blue ocean” opportunities.
Chapter 12: Market Segmentation by Application
This chapter analyzes the market based on application fields, providing insights into the scale and future development of each application segment. It supports readers in identifying high-growth areas across downstream markets.
Chapter 13: Company Profiles
This chapter presents comprehensive profiles of leading companies operating in the market. For each company, it details sales revenue, volume, pricing, gross profit margin, market share, product offerings, and recent strategic developments. This section offers valuable insight into corporate performance and strategy.
Chapter 14: Industry Chain and Value Chain Analysis
This chapter explores the full industry chain, from upstream raw material suppliers to downstream application sectors. It includes a value chain analysis that highlights the interconnections and dependencies across various parts of the ecosystem.
Chapter 15: Key Findings and Conclusions
The final chapter summarizes the main takeaways from the report, presenting the core conclusions, strategic recommendations, and implications for stakeholders. It encapsulates the insights drawn from all previous chapters.
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Oncology Imaging Equipment Market Definition
1.2 Oncology Imaging Equipment Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
2 Executive Summary
2.1 Global Oncology Imaging Equipment Market Size
2.2 Market Segmentation – by Type
2.3 Market Segmentation – by Application
2.4 Market Segmentation – by Geography
3 Key Market Trends, Opportunity, Drivers and Restraints
3.1 Key Takeway
3.2 Market Opportunities & Trends
3.3 Market Drivers
3.4 Market Restraints
3.5 Market Major Factor Assessment
4 Global Oncology Imaging Equipment Market Competitive Landscape
4.1 Global Oncology Imaging Equipment Sales by Manufacturers (2020-2025)
4.2 Global Oncology Imaging Equipment Revenue Market Share by Manufacturers (2020-2025)
4.3 Oncology Imaging Equipment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 New Entrant and Capacity Expansion Plans
4.5 Mergers & Acquisitions
5 Global Oncology Imaging Equipment Market by Region
5.1 Global Oncology Imaging Equipment Market Size by Region
5.1.1 Global Oncology Imaging Equipment Market Size by Region
5.1.2 Global Oncology Imaging Equipment Market Size Market Share by Region
5.2 Global Oncology Imaging Equipment Sales by Region
5.2.1 Global Oncology Imaging Equipment Sales by Region
5.2.2 Global Oncology Imaging Equipment Sales Market Share by Region
6 North America Market Overview
6.1 North America Oncology Imaging Equipment Market Size by Country
6.1.1 USA Market Overview
6.1.2 Canada Market Overview
6.1.3 Mexico Market Overview
6.2 North America Oncology Imaging Equipment Market Size by Type
6.3 North America Oncology Imaging Equipment Market Size by Application
6.4 Top Players in North America Oncology Imaging Equipment Market
7 Europe Market Overview
7.1 Europe Oncology Imaging Equipment Market Size by Country
7.1.1 Germany Market Overview
7.1.2 France Market Overview
7.1.3 U.K. Market Overview
7.1.4 Italy Market Overview
7.1.5 Spain Market Overview
7.1.6 Sweden Market Overview
7.1.7 Denmark Market Overview
7.1.8 Netherlands Market Overview
7.1.9 Switzerland Market Overview
7.1.10 Belgium Market Overview
7.1.11 Russia Market Overview
7.2 Europe Oncology Imaging Equipment Market Size by Type
7.3 Europe Oncology Imaging Equipment Market Size by Application
7.4 Top Players in Europe Oncology Imaging Equipment Market
8 Asia-Pacific Market Overview
8.1 Asia-Pacific Oncology Imaging Equipment Market Size by Country
8.1.1 China Market Overview
8.1.2 Japan Market Overview
8.1.3 South Korea Market Overview
8.1.4 India Market Overview
8.1.5 Australia Market Overview
8.1.6 Indonesia Market Overview
8.1.7 Malaysia Market Overview
8.1.8 Philippines Market Overview
8.1.9 Singapore Market Overview
8.1.10 Thailand Market Overview
8.1.11 Rest of APAC Market Overview
8.2 Asia-Pacific Oncology Imaging Equipment Market Size by Type
8.3 Asia-Pacific Oncology Imaging Equipment Market Size by Application
8.4 Top Players in Asia-Pacific Oncology Imaging Equipment Market
9 South America Market Overview
9.1 South America Oncology Imaging Equipment Market Size by Country
9.1.1 Brazil Market Overview
9.1.2 Argentina Market Overview
9.1.3 Columbia Market Overview
9.2 South America Oncology Imaging Equipment Market Size by Type
9.3 South America Oncology Imaging Equipment Market Size by Application
9.4 Top Players in South America Oncology Imaging Equipment Market
10 Middle East and Africa Market Overview
10.1 Middle East and Africa Oncology Imaging Equipment Market Size by Country
10.1.1 Saudi Arabia Market Overview
10.1.2 UAE Market Overview
10.1.3 Egypt Market Overview
10.1.4 Nigeria Market Overview
10.1.5 South Africa Market Overview
10.2 Middle East and Africa Oncology Imaging Equipment Market Size by Type
10.3 Middle East and Africa Oncology Imaging Equipment Market Size by Application
10.4 Top Players in Middle East and Africa Oncology Imaging Equipment Market
11 Oncology Imaging Equipment Market Segmentation by Type
11.1 Evaluation Matrix of Segment Market Development Potential (Type)
11.2 Global Oncology Imaging Equipment Sales Market Share by Type (2020-2033)
11.3 Global Oncology Imaging Equipment Market Size Market Share by Type (2020-2033)
11.4 Global Oncology Imaging Equipment Price by Type (2020-2033)
12 Oncology Imaging Equipment Market Segmentation by Application
12.1 Evaluation Matrix of Segment Market Development Potential (Application)
12.2 Global Oncology Imaging Equipment Market Sales by Application (2020-2033)
12.3 Global Oncology Imaging Equipment Market Size (M USD) by Application (2020-2033)
12.4 Global Oncology Imaging Equipment Sales Growth Rate by Application (2020-2033)
13 Company Profiles
13.1 GE Healthcare
13.1.1 GE Healthcare Company Overview
13.1.2 GE Healthcare Business Overview
13.1.3 GE Healthcare Oncology Imaging Equipment Major Product Offerings
13.1.4 GE Healthcare Oncology Imaging Equipment Sales and Revenue fromOncology Imaging Equipment (2020-2025)
13.1.5 Key News
13.2 Siemens Healthineers
13.2.1 Siemens Healthineers Company Overview
13.2.2 Siemens Healthineers Business Overview
13.2.3 Siemens Healthineers Oncology Imaging Equipment Major Product Offerings
13.2.4 Siemens Healthineers Oncology Imaging Equipment Sales and Revenue fromOncology Imaging Equipment (2020-2025)
13.2.5 Key News
13.3 Philips Healthcare
13.3.1 Philips Healthcare Company Overview
13.3.2 Philips Healthcare Business Overview
13.3.3 Philips Healthcare Oncology Imaging Equipment Major Product Offerings
13.3.4 Philips Healthcare Oncology Imaging Equipment Sales and Revenue fromOncology Imaging Equipment (2020-2025)
13.3.5 Key News
13.4 Varian Medical Systems
13.4.1 Varian Medical Systems Company Overview
13.4.2 Varian Medical Systems Business Overview
13.4.3 Varian Medical Systems Oncology Imaging Equipment Major Product Offerings
13.4.4 Varian Medical Systems Oncology Imaging Equipment Sales and Revenue fromOncology Imaging Equipment (2020-2025)
13.4.5 Key News
13.5 Canon Medical Systems
13.5.1 Canon Medical Systems Company Overview
13.5.2 Canon Medical Systems Business Overview
13.5.3 Canon Medical Systems Oncology Imaging Equipment Major Product Offerings
13.5.4 Canon Medical Systems Oncology Imaging Equipment Sales and Revenue fromOncology Imaging Equipment (2020-2025)
13.5.5 Key News
13.6 Toshiba Medical Systems
13.6.1 Toshiba Medical Systems Company Overview
13.6.2 Toshiba Medical Systems Business Overview
13.6.3 Toshiba Medical Systems Oncology Imaging Equipment Major Product Offerings
13.6.4 Toshiba Medical Systems Oncology Imaging Equipment Sales and Revenue fromOncology Imaging Equipment (2020-2025)
13.6.5 Key News
13.7 NorthStar Medical Radioisotopes
13.7.1 NorthStar Medical Radioisotopes Company Overview
13.7.2 NorthStar Medical Radioisotopes Business Overview
13.7.3 NorthStar Medical Radioisotopes Oncology Imaging Equipment Major Product Offerings
13.7.4 NorthStar Medical Radioisotopes Oncology Imaging Equipment Sales and Revenue fromOncology Imaging Equipment (2020-2025)
13.7.5 Key News
13.8 Positron
13.8.1 Positron Company Overview
13.8.2 Positron Business Overview
13.8.3 Positron Oncology Imaging Equipment Major Product Offerings
13.8.4 Positron Oncology Imaging Equipment Sales and Revenue fromOncology Imaging Equipment (2020-2025)
13.8.5 Key News
13.9 Neusoft Medical Systems
13.9.1 Neusoft Medical Systems Company Overview
13.9.2 Neusoft Medical Systems Business Overview
13.9.3 Neusoft Medical Systems Oncology Imaging Equipment Major Product Offerings
13.9.4 Neusoft Medical Systems Oncology Imaging Equipment Sales and Revenue fromOncology Imaging Equipment (2020-2025)
13.9.5 Key News
13.10 Cubresa
13.10.1 Cubresa Company Overview
13.10.2 Cubresa Business Overview
13.10.3 Cubresa Oncology Imaging Equipment Major Product Offerings
13.10.4 Cubresa Oncology Imaging Equipment Sales and Revenue fromOncology Imaging Equipment (2020-2025)
13.10.5 Key News
13.11 United Imaging Healthcare
13.11.1 United Imaging Healthcare Company Overview
13.11.2 United Imaging Healthcare Business Overview
13.11.3 United Imaging Healthcare Oncology Imaging Equipment Major Product Offerings
13.11.4 United Imaging Healthcare Oncology Imaging Equipment Sales and Revenue fromOncology Imaging Equipment (2020-2025)
13.11.5 Key News
13.11.6 Key News
14 Key Market Trends, Opportunity, Drivers and Restraints
14.1 Key Takeway
14.2 Market Opportunities & Trends
14.3 Market Drivers
14.4 Market Restraints
14.5 Market Major Factor Assessment
14.6 Porter's Five Forces Analysis of Oncology Imaging Equipment Market
14.7 PEST Analysis of Oncology Imaging Equipment Market
15 Analysis of the Oncology Imaging Equipment Industry Chain
15.1 Overview of the Industry Chain
15.2 Upstream Segment Analysis
15.3 Midstream Segment Analysis
15.3.1 Manufacturing, Processing or Conversion Process Analysis
15.3.2 Key Technology Analysis
15.4 Downstream Segment Analysis
15.4.1 Downstream Customer List and Contact Details
15.4.2 Customer Concerns or Preference Analysis
16 Conclusion
17 Appendix
17.1 Methodology
17.2 Research Process and Data Source
17.3 Disclaimer
17.4 Note
17.5 Examples of Clients
17.6 Disclaimer
Research Methodology
The research methodology employed in this study follows a structured, four-stage process designed to ensure the accuracy, consistency, and relevance of all data and insights presented. The process begins with Information Procurement, wherein data is collected from a wide range of primary and secondary sources. This is followed by Information Analysis, during which the collected data is systematically mapped, discrepancies across sources are examined, and consistency is established through cross-validation.


Subsequently, the Market Formulation phase involves placing verified data points into an appropriate market context to generate meaningful conclusions. This step integrates analyst interpretation and expert heuristics to refine findings and ensure applicability. Finally, all conclusions undergo a rigorous Validation and Publishing process, where each data point is re-evaluated before inclusion in the final deliverable. The methodology emphasizes bidirectional flow and reversibility between key stages to maintain flexibility and reinforce the integrity of the analysis.
Research Process
The market research process follows a structured and iterative methodology designed to ensure accuracy, depth, and reliability. It begins with scope definition and research design, where the research objectives are clearly outlined based on client requirements, emerging market trends, and initial exploratory insights. This phase provides strategic direction for all subsequent stages of the research.
Data collection is then conducted through both secondary and primary research. Secondary research involves analyzing publicly available and paid sources such as company filings, industry journals, and government databases to build foundational knowledge. This is followed by primary research, which includes direct interviews and surveys with key industry stakeholders—such as manufacturers, distributors, and end users—to gather firsthand insights and address data gaps identified earlier. Techniques included CATI (Computer-Assisted Telephonic Interviewing), CAWI (Computer-Assisted Web Interviewing), CAVI (Computer-Assisted Video Interviewing via platforms like Zoom and WebEx), and CASI (Computer-Assisted Self Interviewing via email or LinkedIn).